TB testing in pregnant women in Guinea-Bissau
Part of Infections clinical trials.
This study looks at how common tuberculosis is in pregnant and new mothers. It aims to improve TB detection and care for women in Guinea-Bissau.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be pregnant and 15 years or older.
- You must live in Bandim, Belem, or Cuntum.
- You must be going to checkups at a health center in one of those areas.
- You must agree to take part in the study.
- You cannot be having TB treatment now or have had it in the past year.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a community-based approach to improve tuberculosis (TB) monitoring and screening for immigrants who recently arrived from specific African and Asian countries. It aims to make TB checkups easier to access and understand.
This trial tests a TB screening method to help more pregnant women with HIV get preventive treatment. It aims to find and treat hidden TB early, keeping both mom and baby safer.
This study tests new ways to control the spread of tuberculosis (TB) in high-risk areas of Guangxi, China. It focuses on older adults and people with conditions that make them more likely to get TB.
This study looks at how TB affects people in rural areas who may also be malnourished. It aims to understand and improve TB care for these communities.
This study looks at how tuberculosis (TB) infection might affect the placenta and its function during pregnancy. If you are pregnant and giving birth soon, researchers want to learn if TB changes how the placenta grows and works.
This Phase 3 study tests whether MTBVAC can safely protect newborn babies from tuberculosis and whether it helps the baby’s immune system learn to fight TB. If you enroll, the goal is to see safety and immune response in real newborn settings in sub-Saharan Africa.
Hear when a new Tuberculosis (TB) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.